Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C16H16ClNO2 |
| Molecular Weight | 289.757 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)C(OC(=O)C1=CN=CC=C1)C2=CC=C(Cl)C=C2
InChI
InChIKey=XPPXHQUWVYMTDM-UHFFFAOYSA-N
InChI=1S/C16H16ClNO2/c1-11(2)15(12-5-7-14(17)8-6-12)20-16(19)13-4-3-9-18-10-13/h3-11,15H,1-2H3
| Molecular Formula | C16H16ClNO2 |
| Molecular Weight | 289.757 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/3491930
Male Wistar rats were treated daily for 7 days with nicoclonate (100 mg/kg/d)
Route of Administration:
Oral
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:28:31 GMT 2025
by
admin
on
Mon Mar 31 18:28:31 GMT 2025
|
| Record UNII |
9I4T8U1887
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C29703
Created by
admin on Mon Mar 31 18:28:31 GMT 2025 , Edited by admin on Mon Mar 31 18:28:31 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
10571-59-2
Created by
admin on Mon Mar 31 18:28:31 GMT 2025 , Edited by admin on Mon Mar 31 18:28:31 GMT 2025
|
PRIMARY | |||
|
SUB09232MIG
Created by
admin on Mon Mar 31 18:28:31 GMT 2025 , Edited by admin on Mon Mar 31 18:28:31 GMT 2025
|
PRIMARY | |||
|
1913
Created by
admin on Mon Mar 31 18:28:31 GMT 2025 , Edited by admin on Mon Mar 31 18:28:31 GMT 2025
|
PRIMARY | |||
|
100000084169
Created by
admin on Mon Mar 31 18:28:31 GMT 2025 , Edited by admin on Mon Mar 31 18:28:31 GMT 2025
|
PRIMARY | |||
|
DTXSID20871951
Created by
admin on Mon Mar 31 18:28:31 GMT 2025 , Edited by admin on Mon Mar 31 18:28:31 GMT 2025
|
PRIMARY | |||
|
m842
Created by
admin on Mon Mar 31 18:28:31 GMT 2025 , Edited by admin on Mon Mar 31 18:28:31 GMT 2025
|
PRIMARY | Merck Index | ||
|
C75258
Created by
admin on Mon Mar 31 18:28:31 GMT 2025 , Edited by admin on Mon Mar 31 18:28:31 GMT 2025
|
PRIMARY | |||
|
234-156-8
Created by
admin on Mon Mar 31 18:28:31 GMT 2025 , Edited by admin on Mon Mar 31 18:28:31 GMT 2025
|
PRIMARY | |||
|
3382
Created by
admin on Mon Mar 31 18:28:31 GMT 2025 , Edited by admin on Mon Mar 31 18:28:31 GMT 2025
|
PRIMARY | |||
|
9I4T8U1887
Created by
admin on Mon Mar 31 18:28:31 GMT 2025 , Edited by admin on Mon Mar 31 18:28:31 GMT 2025
|
PRIMARY | |||
|
CHEMBL2107111
Created by
admin on Mon Mar 31 18:28:31 GMT 2025 , Edited by admin on Mon Mar 31 18:28:31 GMT 2025
|
PRIMARY | |||
|
71854
Created by
admin on Mon Mar 31 18:28:31 GMT 2025 , Edited by admin on Mon Mar 31 18:28:31 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |